Literature DB >> 34064062

Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models.

Andrea Capucciati1, Fabio A Zucca2, Enrico Monzani1, Luigi Zecca2, Luigi Casella1, Tim Hofer3.   

Abstract

Neuromelanin (NM) accumulates in catecholamine long-lived brain neurons that are lost in neurodegenerative diseases. NM is a complex substance made of melanic, peptide and lipid components. NM formation is a natural protective process since toxic endogenous metabolites are removed during its formation and as it binds excess metals and xenobiotics. However, disturbances of NM synthesis and function could be toxic. Here, we review recent knowledge on NM formation, toxic mechanisms involving NM, go over NM binding substances and suggest experimental models that can help identifying xenobiotic modulators of NM formation or function. Given the high likelihood of a central NM role in age-related human neurodegenerative diseases such as Parkinson's and Alzheimer's, resembling such diseases using animal models that do not form NM to a high degree, e.g., mice or rats, may not be optimal. Rather, use of animal models (i.e., sheep and goats) that better resemble human brain aging in terms of NM formation, as well as using human NM forming stem cellbased in vitro (e.g., mid-brain organoids) models can be more suitable. Toxicants could also be identified during chemical synthesis of NM in the test tube.

Entities:  

Keywords:  MPTP; adverse outcome pathway (AOP); iron; locus coeruleus; quinone; substantia nigra

Year:  2021        PMID: 34064062     DOI: 10.3390/antiox10060824

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  140 in total

1.  Magnetic beads method for determination of binding of drugs to melanin.

Authors:  Michał Piotr Marszałł; Adam Buciński; Krzysztof Goryński; Anna Proszowska; Roman Kaliszan
Journal:  J Chromatogr A       Date:  2010-11-21       Impact factor: 4.759

Review 2.  Structure-function correlations in tyrosinases.

Authors:  Margarita Kanteev; Mor Goldfeder; Ayelet Fishman
Journal:  Protein Sci       Date:  2015-07-07       Impact factor: 6.725

3.  Neuromelanin inhibits CXCL10 expression in human astroglial cells.

Authors:  Neda Saffarian Tousi; Daniel J Buck; Luigi Zecca; Randall L Davis
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

4.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

5.  The structure of neuromelanin as studied by chemical degradative methods.

Authors:  Kazumasa Wakamatsu; Kenichi Fujikawa; Fabio A Zucca; Luigi Zecca; Shosuke Ito
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

6.  Long-term retention of neurotoxic beta-carbolines in brain neuromelanin.

Authors:  A Ostergren; A Annas; K Skog; N G Lindquist; E B Brittebo
Journal:  J Neural Transm (Vienna)       Date:  2003-12-03       Impact factor: 3.575

7.  Methyl-beta-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats.

Authors:  E J Neafsey; R Albores; D Gearhart; G Kindel; K Raikoff; F Tamayo; M A Collins
Journal:  Brain Res       Date:  1995-03-27       Impact factor: 3.252

8.  Dose-Dependent Adult Neurodegeneration in a Rat Model After Neonatal Exposure to β-N-Methylamino-L-Alanine.

Authors:  Laura Scott; Timothy Downing
Journal:  Neurotox Res       Date:  2019-01-21       Impact factor: 3.911

Review 9.  Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist
Journal:  Arch Toxicol       Date:  2016-06-16       Impact factor: 5.153

10.  The influence of iron on selected properties of synthetic pheomelanin.

Authors:  Andrzej Zadlo; Krystian Mokrzyński; Shosuke Ito; Kazumasa Wakamatsu; Tadeusz Sarna
Journal:  Cell Biochem Biophys       Date:  2020-05-24       Impact factor: 2.194

View more
  3 in total

Review 1.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

2.  Risk of Migraine in Europeans with Low Melanin Levels-A Population Based Case-Control Study.

Authors:  Magdalena Kobus; Elżbieta Żądzińska; Aneta Sitek; Jacek Pełka; Jacek J Rożniecki; Bogusław Antoszewski
Journal:  Brain Sci       Date:  2022-05-10

3.  Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids.

Authors:  Jia Shang; Bin Li; Han Fan; Peidi Liu; Wen Zhao; Tao Chen; Pu Chen; Longqiu Yang
Journal:  Front Cell Dev Biol       Date:  2022-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.